Screening of Endovascular Thrombectomy With MRI in Acute Ischemic Stroke

Status Completed

Clinical Trial Summary

The goal of this observational study is to learn about the role of MRI evaluation based on FVH-DWI mismatch principle in preoperative evaluation of endovascular thrombolectomy. The main questions it aims to answer are: - The consistency between MRI and perfusion examination in determining EVT indications. - The consistency of functional independence rate between patients screening with MRI and perfusion.

Clinical Trial Description

MRI is the preferred imaging mode in many centers,for the diffusion-weighted imaging (DWI) sequences are highly sensitive to acute cerebral ischemia.In addition, MRI does not require intravenous contrast agent, which is simpler and more popular than perfusion.Fluid-attenuated inversion recovery (FLAIR)sequence vascular hyperintensity(FVH) is defined as focal, serpentine, or linear hyperintensity that usually occurs in the Sylvian fissure and is associated with large-vessel occlusion or stenosis.The FVH-DWI mismatch(defined as the FVH extended beyond the boundary of the DWI cortical lesions) had been confirmed has excellent sensitivity and specificity in predicting PWI-DWI mismatch.It is not well established whether MRI based on FVH-DWI mismatch and perfusion evaluation differ in determining EVT indications and outcomes. The main objectives of this study were to (1) determine the proportion of patients eligible for EVT surgery selected by MRI based on FVH-DWI mismatch vs perfusion in a large multicenter registry and (2) identify statistical differences in functional outcomes and safety outcomes between the two evaluation methods. Patients with ischemic stroke with anterior-circulation large-vessel occlusion in the late (6-24 h) time window from real-world, single center retrospective cohort registry were compared.In the MRI group, patients with FVH-DWI mismatch underwent EVT surgery or were otherwise treated with medication.In the perfusion group, surgical indications referring the DEFUSE 3 standards. The primary outcome was 90-day functional independence rate (mRS score ≤2) in all patients included(including EVT patient and medication patients).Safety outcomes included symptomatic intracranial hemorrhage (sICH), and 90-day mortality. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06213870
Study type	Observational
Source	Tianjin Huanhu Hospital
Contact
Status	Completed
Phase
Start date	August 1, 2022
Completion date	November 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04484350` - Blood Pressure Management in Stroke Following Endovascular Treatment	Phase 2
Recruiting	`NCT04121611` - Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation	N/A
Recruiting	`NCT04517383` - Effects of Post-Operative Sedation for Endovascular Thrombectomy	N/A
Enrolling by invitation	`NCT06361017` - The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy
Recruiting	`NCT05708079` - Multidimensional Evaluation of Patients With Acute Ischemic Stroke Undergoing Pharmacological and Endovascular Revascularization Procedures for the Identification of Positive Prognostic Factors
Recruiting	`NCT06094569` - Medical Imaging Screening for Posterior-circulation Ischemic Stroke
Completed	`NCT05684172` - Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation	Phase 2/Phase 3
Completed	`NCT04116112` - Blood Pressure After Endovascular Stroke Therapy-II	Phase 2
Completed	`NCT06290076` - A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy
Recruiting	`NCT05735301` - MR Imaging Selection for Endovascular Treatment in Acute Ischemic Stroke at 6 to 24 Hours	N/A
Recruiting	`NCT06200753` - Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)
Completed	`NCT04667637` - Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol	Phase 2
Recruiting	`NCT06146790` - Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.